266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies

Detalles Bibliográficos
Autores principales: Puttagunta, Sailaja, Boucher, Helen, Talbot, George, Wilcox, Mark, Dunne, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
IDWeek 2014 Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781625/
http://dx.doi.org/10.1093/ofid/ofu052.132
_version_ 1783294999717216256
author Puttagunta, Sailaja
Boucher, Helen
Talbot, George
Wilcox, Mark
Dunne, Michael
author_facet Puttagunta, Sailaja
Boucher, Helen
Talbot, George
Wilcox, Mark
Dunne, Michael
author_sort Puttagunta, Sailaja
collection PubMed
description
format Online
Article
Text
id pubmed-5781625
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57816252018-03-01 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies Puttagunta, Sailaja Boucher, Helen Talbot, George Wilcox, Mark Dunne, Michael Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781625/ http://dx.doi.org/10.1093/ofid/ofu052.132 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Puttagunta, Sailaja
Boucher, Helen
Talbot, George
Wilcox, Mark
Dunne, Michael
266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title_full 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title_fullStr 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title_full_unstemmed 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title_short 266 Dalbavancin vs Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
title_sort 266 dalbavancin vs vancomycin for the treatment of acute bacterial skin and skin structure infections (absssi): a subanalysis from the discover studies
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781625/
http://dx.doi.org/10.1093/ofid/ofu052.132
work_keys_str_mv AT puttaguntasailaja 266dalbavancinvsvancomycinforthetreatmentofacutebacterialskinandskinstructureinfectionsabsssiasubanalysisfromthediscoverstudies
AT boucherhelen 266dalbavancinvsvancomycinforthetreatmentofacutebacterialskinandskinstructureinfectionsabsssiasubanalysisfromthediscoverstudies
AT talbotgeorge 266dalbavancinvsvancomycinforthetreatmentofacutebacterialskinandskinstructureinfectionsabsssiasubanalysisfromthediscoverstudies
AT wilcoxmark 266dalbavancinvsvancomycinforthetreatmentofacutebacterialskinandskinstructureinfectionsabsssiasubanalysisfromthediscoverstudies
AT dunnemichael 266dalbavancinvsvancomycinforthetreatmentofacutebacterialskinandskinstructureinfectionsabsssiasubanalysisfromthediscoverstudies

Ejemplares similares